ArticleAntioxidants (Basel, Switzerland)2021

Saracatinib, a Src Tyrosine Kinase Inhibitor, as a Disease Modifier in the Rat DFP Model: Sex Differences, Neurobehavior, Gliosis, Neurodegeneration, and Nitro-Oxidative Stress.

Meghan Gage et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.